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Incidental renal cell carcinoma identiﬁed at
laparoscopic donor nephrectomy presents a
challenge requiring multidisciplinary input to
achieve an optimum outcome.
Case report
A 41-year-old man was admitted to hospital to
undergo a left laparoscopic live donor nephrect-
omy. The recipient was his 49-year-old sister
with autosomal dominant polycystic kidney
disease, and a history of non-Hodgkin’s lym-
phoma, previously treated with chemotherapy
and subsequent stem cell rescue.
Preoperative donor work-up had revealed con-
ventional vascular anatomy, with the left kidney
contributing 45% to overall function. In addition,
a small (7 mm) hypodense lesion was identiﬁed
in the left kidney which was felt to be a benign
cyst (Figure 1).
The donor underwent an uncomplicated
laparoscopic donor nephrectomy. The operative
duration was 110 minutes; the kidney was deliv-
ered via a Pfannenstiel incision.
During bench preparation of the kidney, it
became apparent that the reported lesion was in
fact a small solid mass. The decision was made
to excise the lesion from the kidney and perform
an immediate frozen section. This reported a
fully excised papillary renal cell carcinoma
(Figures 2a and 2b). The renal defect was closed
using a perirenal fat interposition.
The recipient underwent urgent counselling
concerning the intraoperative ﬁndings regarding
the donor kidney. Options discussed were dis-
carding of the kidney or proceeding with trans-
plantation. With the latter she was advised that
there was a small risk of tumour recurrence and
the potential implications of this. After extensive
discussions with family she elected to be trans-
planted with the kidney. The cold-ischaemia
time was approximately 180 minutes.
Both the recipient and donor were discharged
on day 5 without complication. The graft func-
tioned immediately achieving a serum creatinine
of 97 umol/L (estimated GFR 55 mL/min). The
subsequent parafﬁn section report revealed a
fully excised type 1 papillary renal cell carcinoma,
Fuhrman’s Grade 1–2 (T1a).
The case was discussed at local and regional
multidisciplinary cancer meetings, and it was
elected to perform surveillance of donor and
recipient with serial ultrasound scanning.
Discussion
Renal transplantation is the preferred option for
most patients with end-stage renal failure.
Live-related donors are increasingly utilized, and
for recipients this is the most attractive and suc-
cessful intervention in terms of patient and graft
survival.
1,2 Unfortunately, the number of patients
receiving transplantation is limited by the avail-
ability of organs.
3
Our case serves to expand the debate regarding
the transplanting of kidneys with small renal
tumours excised following donor nephrectomy.
It is the ﬁrst description of a case where the diag-
nosis was made intraoperatively at the time of
laparoscopic donor nephrectomy. It follows that
with increasing rates of transplantation that this
situation may occur more frequently in the future.
Brook et al.
4 have reported the largest series of
transplants with previously diagnosed small
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1(<3 cm) renal tumours, and compared outcomes
to patients receiving kidneys from live unrelated
donors as well as dialysis ‘waiting-listed’ patients.
In their series of 43 patients, who were all >60
years old with signiﬁcant co-morbidities, patient
survival was comparable in the two transplanted
groups, and signiﬁcantly better than those who
remained on dialysis waiting for transplants.
Twenty-ﬁve patients had excised clear cell carci-
nomas, and there were ﬁve papillary carcinomas
(as in our case). The potential risk of immuno-
supression and tumour recurrence did not seem
to be a problem in transplanted patients. One of
their patients developed a small lesion (1.2 cm)
distant from the original resection site, and this
was managed conservatively.
A further smaller series followed up ﬁve
patients who had been transplanted with
kidneys containing (back-table excised) small
(<2.3 cm) renal masses, three of which transpired
to be renal cell carcinomas.
5 Cancer speciﬁc survi-
val was 100% in this series, although median
follow-up was only 15 months.
These reported series addressed the concept of
using ‘marginal’ kidneys in high-risk dialysis
patients, in whom the morbidity of dialysis was
likely to heavily outweigh the risks conveyed by
transplanting kidneys previously containing a
small tumour. One assumption is that these (sub-
sequently immunosupressed) patients behave in
the same way as non-immunocompromised
patients, in as far as partial nephrectomy has
the same cancer-speciﬁc survival as radical
nephrectomy.
6
Clearly the follow-up of such donors (and reci-
pients) has yet to be deﬁned, but such strategies
should monitor for both local recurrence (e.g.
ultrasound) and metastatic disease (intermittent
CT) in both donor and recipient, although the like-
lihood of small ‘low-risk’ tumours recurring is
probably small even in this patient group.
Our case is somewhat different in that the
diagnosis was made intraoperatively at the time
of laparoscopic nephrectomy. In addition, our
recipient may not have been considered to be in
the ‘high-risk’ groups studied above. Obviously
Figure 1
Preoperative CT demonstrating small hypodense
lesion (15 HU) in left kidney
Figure 2
a. (low power); and b. (high power) Type 1 papil-
lary renal cell carcinoma (Fuhrman’s Grade 1–2),
surrounded by a ﬁbrous capsule, but with focal
extension through the capsule into the renal
parenchyma
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2patients in this situation need to be carefully coun-
selled with regard to the implications of proceed-
ing with the transplant. This should be performed
in a multidisciplinary fashion, ideally without
unduly prolonging the cold-ischaemia time. The
risks of continued renal dialysis should,
however, not be understated.
In situations such as we describe, transplant
clinicians should be prepared to discuss the
option of transplantation with recipients, explain-
ing the potential risks of tumour recurrence as
well as the alternatives of ongoing dialysis or
transplantation from another donor source.
While not all patients may be comfortable with
transplantation of kidneys, many may chose to
proceed and should be provided with the oppor-
tunity to do so given the potential beneﬁts and
likely small risk.
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